AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...

Some people with Parkinson’s Disease are turning to improv to boost their cognitive skills and spend more time with others.

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

“There’s really no definitive test in life to know whether someone has Parkinson’s disease. And so that really leads to a lot of uncertainty, but it also misdiagnosis unfortunately,” said Laurie H.

Research examined medical records from over one million people to uncover early indicators of the incurable condition.

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

Parkinson’s disease is a progressive neurological disorder that affects millions of people worldwide, including 1,500 people ...